Company Description
Cresco Labs Inc. engages in the business of cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains ...
Cresco Labs Inc. engages in the business of cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
Valuation
Price to Sales Ratio
6.20
Price to Book Ratio
4.86
Enterprise Value to Sales
7.54
Total Debt to Enterprise Value
0.10
Efficiency
Revenue/Employee
121,822.00
Income Per Employee
-40,945.00
Receivables Turnover
9.04
Total Asset Turnover
0.28
Liquidity
Current Ratio
1.06
Quick Ratio
0.52
Cash Ratio
0.36
Profitability
Gross Margin
-38.64
Operating Margin
-110.68
Pretax Margin
-39.51
Net Margin
-33.61
Return on Assets
-9.29
Return on Equity
-28.11
Return on Total Capital
-40.66
Return on Invested Capital
-22.22
Capital Structure
Total Debt to Total Equity
51.01
Total Debt to Total Capital
33.78
Total Debt to Total Assets
15.48
Long-Term Debt to Equity
44.58
Long-Term Debt to Total Capital
29.52
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Mr. Charles Bachtell | 40 | - | Chief Executive Officer & Director |
| Mr. Ty Gent | - | 2021 | Chief Operating Officer |
| Mr. Dennis M. Olis | 56 | 2020 | Chief Financial Officer |
| Mr. Mo Dastagir | 42 | 2019 | Chief Information Officer |
| Mr. Greg Butler | - | 2020 | Chief Commercial Officer |
Insider Actions
MarketWatch News on CRLBF
-
Cresco Labs started at buy with C$25 stock price target at Alliance Global Partners
- Tomi Kilgore
-
Cresco Labs closes sale-and-leaseback of Massachusetts facility
- Ciara Linnane
-
Cresco Labs says President Joe Caltabiano is resigning with immediate effect
- Ciara Linnane
-
Cresco Labs initiated as overweight at Cantor Fitzgerald
- Ciara Linnane
-
Cresco Labs gets $100 million in senior secured term loan
- Ciara Linnane
-
Cresco Labs has option to increase loan to up to $200 mln
- Ciara Linnane
-
Cresco Labs gets senior secured term loan with initial principal amount of up to $100 mln
- Ciara Linnane
-
Cannabis stocks led lower by Aurora and Hexo
- Max A. Cherney
-
Weed stocks rally on last day of a brutal year
- Max A. Cherney
- Loading more headlines...
Other News on CRLBF
-
Cansortium: One Of Few Remaining Florida Cannabis Gems
- Seeking Alpha
-
Indus Holdings to buy cannabis company Lowell Herb for $39m
- Seeking Alpha
-
8 Medical Marijuana Stocks That Are Just What the Doctor Ordered
- InvestorPlace.com
-
Green Thumb: The $100 Million Vote Of Confidence
- Seeking Alpha
-
Curaleaf: The Priciest But Not The Strongest Of The Big 4 MSOs
- Seeking Alpha
-
Cresco Labs closes the Verdant acquisition in Ohio
- Seeking Alpha
-
Cannabis - Trade Canadian MJ, Invest In MSOS
- Seeking Alpha
-
Ayr Strategies: This Upstart Consolidator Will Keep Growing
- Seeking Alpha
-
7 Marijuana Stocks Ready To Surge Again
- InvestorPlace.com
-
8 Cheap Stocks Under $20 That Could Double
- InvestorPlace.com
-
The Rally Of U.S. Cannabis Stocks Is Just Beginning
- Seeking Alpha
-
The New Dawn In Cannabis Has Arrived
- Seeking Alpha
-
Cannabis In California Will Boom Into A Powerhouse Opportunity
- Seeking Alpha
-
Cresco Labs (CRLBF) Investor Presentation - Slideshow
- Seeking Alpha
-
Liberty Health: Ayr Strategies Is A Great Exit Plan
- Seeking Alpha
- Loading more headlines...
